- Exchange: NASDAQ GM
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Amicus Therapeutics Inc
+ Add to WatchlistFOLD:US
3.4000 USD 0.0200 0.58%As of 20:10:00 ET on 05/24/2013.
Company Profile for Amicus Therapeutics Inc (FOLD)
Amicus Therapeutics, Inc. is a biopharmaceutical company that develops orally-administered, small molecule drugs to treat human genetic diseases. The drugs, called pharmacological chaperones, are being developed to treat Fabray, Gaucher, and Pompe disease.
Contact Information
Amicus Therapeutics Inc
6 Cedar Brook Drive
Cranbury, NJ 08512
United States
Phone: 1-609-662-2000
Key Executives for Amicus Therapeutics Inc (FOLD)
| John F CrowleyChairman/CEO | William D Baird III "Chip"Chief Financial Officer |
| David J LockhartChief Scientific Officer | Bradley L CampbellChief Business Officer |
| Peter M MacalusoVP/Secretary/Counsel | John R KirkVP:Regulatory Affairs |
| Ken ValenzanoVP:Pharmacology | Kenneth W PeistVP:Intellectual Property |
| Enrique DiloneVP:Technical Operations | Daphne QuimiController |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Advertisements
Rate this Page